SINTX Technologies, Inc.

Contributing Author

Recent Articles by SINTX Technologies, Inc.

Mar-23	SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution SINT GlobeNewswire
Mar-19	SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC Foot & Ankle Implant SINT GlobeNewswire
Feb-18	SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms SINT GlobeNewswire
Jan-29	SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4-5 SINT GlobeNewswire
Dec-08	SINTX Technologies to Participate in Sidoti & Company Investor Conference SINT GlobeNewswire
Dec-01	SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride-PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants SINT -21.20% GlobeNewswire
Nov-13	SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies SINT -10.79% GlobeNewswire
Nov-03	SINTX Technologies Announces Launch of OsseoSculpt an Advanced Biologic for Use with SINAPTIC Foot & Ankle Osteotomy Wedge System SINT GlobeNewswire
Oct-20	SINTX Technologies Receives FDA Clearance for SINAPTIC Foot & Ankle Implant System SINT -15.40% GlobeNewswire
Oct-16	UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market SINT -5.35% GlobeNewswire
Oct-14	SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics SINT GlobeNewswire
Sep-09	SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025 SINT -7.63% GlobeNewswire
Sep-08	SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds SINT -16.70% GlobeNewswire
Sep-08	SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent SINT -16.70% GlobeNewswire
Sep-03	SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride SINT +15.97% GlobeNewswire
Aug-15	SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition SINT GlobeNewswire
Aug-04	SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates SINT +11.25% GlobeNewswire
Jul-22	SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices SINT -5.76% GlobeNewswire
Jun-24	SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market SINT GlobeNewswire
Jun-12	SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors SINT +6.46% GlobeNewswire
May-22	SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market SINT -7.57% GlobeNewswire
May-15	SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization SINT GlobeNewswire

SINTX Technologies, Inc.

Recent Articles by SINTX Technologies, Inc.

Upgrade your Finviz experience